» Articles » PMID: 23172760

Discrimination of Metastatic Lymph Nodes in Patients with Gastric Carcinoma Using Diffusion-weighted Imaging

Overview
Date 2012 Nov 23
PMID 23172760
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To determine the accuracy of diffusion-weighted imaging (DWI) in discrimination of metastatic lymph nodes (LNs) in gastric carcinoma with rigorous histopathological correlation.

Materials And Methods: With Institutional Review Board (IRB) approval, 28 patients with gastric carcinoma underwent magnetic resonance imaging (MRI) and DWI before surgery. LNs were resected at surgery and thereafter submitted for histopathological analyses. All histopathologically identified LNs (≥ 5 mm) that exactly matched the location and size of nodes on MRI/DWI were submitted to lesion-by-lesion analyses. Short-axis diameter, border irregularity, enhanced patterns, and apparent diffusion coefficient (ADC) values of each LN were recorded. Each measurement was compared between metastatic and benign LNs, confirmed by nodal histopathology. A receiver operating characteristic (ROC) curve was generated to evaluate the capability of morphological and ADC measurements in distinguishing metastatic lymph nodes.

Results: The median ADC value of metastatic nodes was significantly lower (1.28 × 10(-3) mm(2) /sec; interquartile range, 1.20-1.31) than that of benign (1.55; 1.47-1.73) nodes (P < 0.001). DWI showed greater diagnostic accuracy in determining metastatic nodes (AUC = 0.857) than the combined morphological measurements of short-axis, border irregularity, and enhanced patterns (AUC = 0.746, P = 0.03). Adding ADC values to the combined morphologic criteria demonstrated the greatest predictive power (AUC = 0.889).

Conclusion: DWI may provide great potential in effective discrimination of metastatic LNs in gastric carcinoma.

Citing Articles

Robustness of apparent diffusion coefficient-based lymph node classification for diagnosis of prostate cancer metastasis.

Noto B, Eveslage M, Auf der Springe K, Exler A, Faldum A, Heindel W Eur Radiol. 2023; 34(7):4504-4515.

PMID: 38099965 PMC: 11213742. DOI: 10.1007/s00330-023-10406-8.


Prediction of hepatic lymph node metastases based on magnetic resonance imaging before and after preoperative chemotherapy in patients with colorectal liver metastases underwent surgical resection.

Zhu H, Xu D, Sun X, Li X, Zhang X, Wang K Cancer Imaging. 2023; 23(1):18.

PMID: 36810192 PMC: 9942330. DOI: 10.1186/s40644-023-00529-y.


Gastric Cancer Staging: Is It Time for Magnetic Resonance Imaging?.

Renzulli M, Clemente A, Spinelli D, Ierardi A, Marasco G, Farina D Cancers (Basel). 2020; 12(6).

PMID: 32485933 PMC: 7352169. DOI: 10.3390/cancers12061402.


The role of MRI in the diagnosis and treatment of gastric cancer.

Zhang Y, Yu J Diagn Interv Radiol. 2020; 26(3):176-182.

PMID: 32209504 PMC: 7239361. DOI: 10.5152/dir.2019.19375.


The primary lesion apparent diffusion coefficient is a prognostic factor for locoregionally advanced nasopharyngeal carcinoma: a retrospective study.

Huang T, Lu N, Lian S, Li H, Yin S, Geng Z BMC Cancer. 2019; 19(1):470.

PMID: 31101029 PMC: 6525458. DOI: 10.1186/s12885-019-5684-3.